Cocrystal Pharma Financial Overview
Cocrystal Pharma's market cap is currently $13.43M. The company's EPS TTM is $-0.19; its P/E ratio is -1.04; Cocrystal Pharma is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
